Safety of the patient must be considered as the reference point for the producers of compounds for the pharmaceutical market.In this paper, starting from the case study of Brexpiprazole, we describe the essential aspects connected to the development of sustainable processes for the production of Active Pharmaceutical Ingredients (APIs).